Arrowstreet Capital Limited Partnership bought a new stake in shares of Cognex Co. ( NASDAQ:CGNX – Free Report ) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 160,117 shares of the scientific and technical instruments company’s stock, valued at approximately $5,742,000.
Arrowstreet Capital Limited Partnership owned 0.09% of Cognex as of its most recent SEC filing. Several other institutional investors and hedge funds have also recently bought and sold shares of the company.
Verition Fund Management LLC acquired a new position in shares of Cognex during the third quarter worth approximately $306,000. Quantinno Capital Management LP acquired a new position in Cognex during the 3rd quarter worth $342,000. Stifel Financial Corp grew its stake in shares of Cognex by 23.
8% in the third quarter. Stifel Financial Corp now owns 71,002 shares of the scientific and technical instruments company’s stock worth $2,876,000 after purchasing an additional 13,643 shares in the last quarter. State Street Corp increased its holdings in shares of Cognex by 0.
8% during the third quarter. State Street Corp now owns 5,190,365 shares of the scientific and technical instruments company’s stock valued at $210,210,000 after purchasing an additional 42,882 shares during the period. Finally, Weiss Asset Management LP bought a new stake in shares of Cognex during the third quarter valued at about $1,256,000.
Institutional investors own 88.12% of the company’s stock. Wall Street Analysts Forecast Growth CGNX has been the subject of a number of recent analyst reports.
The Goldman Sachs Group decreased their target price on shares of Cognex from $39.00 to $35.00 and set a “sell” rating for the company in a research report on Tuesday, February 18th.
Hsbc Global Res lowered shares of Cognex from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 21st. Truist Financial restated a “hold” rating and issued a $37.00 target price (down from $43.
00) on shares of Cognex in a research report on Friday, February 14th. Needham & Company LLC lowered their price target on Cognex from $47.00 to $41.
00 and set a “buy” rating on the stock in a research report on Friday, February 14th. Finally, UBS Group cut their price objective on Cognex from $58.00 to $56.
00 and set a “buy” rating for the company in a report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $44.
83. Cognex Stock Performance Cognex stock opened at $24.51 on Tuesday.
Cognex Co. has a 52 week low of $23.10 and a 52 week high of $53.
13. The firm has a market capitalization of $4.15 billion, a price-to-earnings ratio of 40.
18 and a beta of 1.56. The company has a 50 day moving average price of $33.
35 and a 200 day moving average price of $37.03. Cognex ( NASDAQ:CGNX – Get Free Report ) last issued its earnings results on Wednesday, February 12th.
The scientific and technical instruments company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.
01). Cognex had a return on equity of 5.65% and a net margin of 11.
61%. Equities analysts forecast that Cognex Co. will post 0.
61 earnings per share for the current fiscal year. Cognex Dividend Announcement The business also recently declared a quarterly dividend, which was paid on Thursday, March 13th. Stockholders of record on Thursday, February 27th were given a $0.
08 dividend. This represents a $0.32 dividend on an annualized basis and a dividend yield of 1.
31%. The ex-dividend date of this dividend was Thursday, February 27th. Cognex’s dividend payout ratio (DPR) is 52.
46%. Insider Buying and Selling In related news, EVP Carl Gerst sold 6,803 shares of Cognex stock in a transaction on Monday, February 24th. The stock was sold at an average price of $32.
73, for a total transaction of $222,662.19. Following the completion of the sale, the executive vice president now owns 4,566 shares of the company’s stock, valued at approximately $149,445.
18. This trade represents a 59.84 % decrease in their ownership of the stock.
The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website . 1.60% of the stock is currently owned by corporate insiders.
Cognex Profile ( Free Report ) Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. Read More Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.
com's FREE daily email newsletter ..
Business
160,117 Shares in Cognex Co. (NASDAQ:CGNX) Purchased by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership bought a new stake in shares of Cognex Co. (NASDAQ:CGNX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 160,117 shares of the scientific and technical instruments company’s stock, valued at approximately $5,742,000. Arrowstreet Capital Limited Partnership owned 0.09% [...]